Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy

• Главные авторы: Ling Kong (Автор), Ye Sun (Автор), Hui Sun (Автор), Ai-hua Zhang (Автор), Bo Zhang (Автор), Nan Ge (Автор), Xi-jun Wang (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Keluoxin (KLX) is an active agent in the treatment of diabetic retinopathy (DR). However, its mechanism, targets, and effective constituents against DR are still unclear, which seriously restricts its clinical application. Chinmedomics has the promise of explaining the pharmacological effects of her...